Drugs / Dendritic Cell based p53 Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03406715 | Mar 2018 → Mar 2022 | small cell lung carcinoma | H. Lee Moffitt Cancer Center and Research Institute | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic Cell based p53 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03406715 ↗ |
| Modality | Vaccine | “Dendritic Cell based p53 Vaccine (Ad.p53-DC).” NCT03406715 ↗ |